Search

Your search keyword '"Boutonneuse Fever immunology"' showing total 127 results

Search Constraints

Start Over You searched for: Descriptor "Boutonneuse Fever immunology" Remove constraint Descriptor: "Boutonneuse Fever immunology"
127 results on '"Boutonneuse Fever immunology"'

Search Results

1. Seroprevalences of Rickettsia conorii, Ehrlichia canis and Coxiella burnetii in Dogs from Montenegro.

2. Graft-versus-host disease after an infection by Rickettsia conorii induced by a tick's bite.

3. Rickettsia conorii is a potent complement activator in vivo and combined inhibition of complement and CD14 is required for attenuation of the cytokine response ex vivo.

4. Evaluation of a new serological test for the detection of anti-Coxiella and anti-Rickettsia antibodies.

5. T-Lymphocyte Subset Absolute Counts in the Peripheral Blood of Mediterranean Spotted Fever Patients: Relations to Disease Severity.

6. Rickettsial meningitis.

7. Skin lesions and inoculation eschars at the tick bite site in spotted fever group rickettsioses: experience from a patient series in eastern crete, Greece.

8. Rickettsioses in the central hills of Sri Lanka: serological evidence of increasing burden of spotted fever group.

9. Detection of natural killer T cells in mice infected with Rickettsia conorii.

10. Levels of certain endothelial biomarkers during the acute phase and convalescence in patients with different severity of Mediterranean spotted fever.

11. OmpA-mediated rickettsial adherence to and invasion of human endothelial cells is dependent upon interaction with α2β1 integrin.

13. Cross-protection among Rickettsia species and subspecies in a guinea pig model of cutaneous infection.

14. Clinically helpful rickettsial disease diagnostic IgG titers in relation to duration of illness in an endemic setting in Sri Lanka.

15. Contribution of NK cells to the innate phase of host protection against an intracellular bacterium targeting systemic endothelium.

16. A complex interaction between Rickettsia conorii and Dickkopf-1--potential role in immune evasion mechanisms in endothelial cells.

17. Molecular basis of immunity to rickettsial infection conferred through outer membrane protein B.

18. [Emergence of tick-borne spotted fever group rickettsiosis in Moscow].

19. Dynamics in serum cytokine responses during acute and convalescent stages of Mediterranean spotted fever.

20. [Pediatric Mediterranean spotted fever].

21. CD4+ CD25+ Foxp3- T-regulatory cells produce both gamma interferon and interleukin-10 during acute severe murine spotted fever rickettsiosis.

22. Relevance of gamma interferon, tumor necrosis factor alpha, and interleukin-10 gene polymorphisms to susceptibility to Mediterranean spotted fever.

23. Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever.

24. Retinopathy in Rickettsia conorii infection: case report in an immunocompetent host.

25. The absence of Toll-like receptor 4 signaling in C3H/HeJ mice predisposes them to overwhelming rickettsial infection and decreased protective Th1 responses.

26. Indian tick typhus mimicking as Rocky Mountain Spotted Fever: a case report.

27. Intralesional expression of mRNA of interferon- gamma , tumor necrosis factor- alpha , interleukin-10, nitric oxide synthase, indoleamine-2,3-dioxygenase, and RANTES is a major immune effector in Mediterranean spotted fever rickettsiosis.

28. Rickettsiae-stimulated dendritic cells mediate protection against lethal rickettsial challenge in an animal model of spotted fever rickettsiosis.

29. Differential interaction of dendritic cells with Rickettsia conorii: impact on host susceptibility to murine spotted fever rickettsiosis.

30. Characterisation of rickettsial diseases in a hospital-based population in Malta.

31. Evaluation of IgG antibody response against Rickettsia conorii and Rickettsia slovaca in patients with DEBONEL/TIBOLA.

32. The seroprevalence of human infection with Rickettsia slovaca, in an area of northern Spain.

33. Expression of CX3CL1 (fractalkine) in mice with endothelial-target rickettsial infection of the spotted-fever group.

34. Seroepidemiology of spotted fever group and typhus group rickettsioses in humans, South Korea.

35. Effect of blocking the CXCL9/10-CXCR3 chemokine system in the outcome of endothelial-target rickettsial infections.

37. [Rickettsiosis after a stay in South Africa].

38. [Spotted fever Rickettsiae. Their immunodominant proteins and immune response].

39. Emerging rickettsial infections in Sri Lanka: the pattern in the hilly Central Province.

40. A case of pleurisy associated with antibodies to Rickettsia conorii.

41. Kinetics of antibody responses in Rickettsia africae and Rickettsia conorii infections.

42. Randomized trial of azithromycin in the prophylaxis of Mediterranean spotted fever.

43. [Status of cellular immunity in patients with Astrakhan fever].

44. Study on immunobiology in ectoparasites of public health interest: Rhipicephalus sanguineus.

45. Rickettsial infection in murine models activates an early anti-rickettsial effect mediated by NK cells and associated with production of gamma interferon.

46. [Mediterranean spotted fever complicated by myocarditis].

47. Critical role of cytotoxic T lymphocytes in immune clearance of rickettsial infection.

48. The acute phase response in Sicilian patients with boutonneuse fever admitted to hospitals in Palermo, 1992-1997.

49. Interleukin-12 in human boutonneuse fever caused by Rickettsia conorii.

50. Differential up-regulation of circulating soluble selectins and endothelial adhesion molecules in Sicilian patients with Boutonneuse fever.

Catalog

Books, media, physical & digital resources